(c) 2024 PillSync.com

sulfamethoxazole and trimethoprim tablet

INDICATIONS AND USAGE: To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria R . When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Urinary Tract Infections: For the treatment of Urinary Tract Infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis and Proteus vulgaris. It is recommended that initial episodes of uncomplicated Urinary Tract Infections be treated with a single effective antibacterial agent rather than the combination. Acute Otitis Media: For the treatment of Acute Otitis Media in pediatric patients due to susceptible strains of Pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents. To date, there are limited data on the safety of repeated use of sulfamethoxazole and trimethoprim in pediatric patients under two years of age. Sulfamethoxazole and trimethoprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Acute Exacerbations of Chronic Bronchitis in Adults: For the treatment of acute exacerbations of Chronic Bronchitis due to susceptible strains of Streptococcus Pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of a single antimicrobial agent. Shigellosis: For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated. Pneumocystis Carinii Pneumonia: For the treatment of documented Pneumocystis carinii Pneumonia and for prophylaxis against Pneumocystis carinii Pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing Pneumocystis carinii Pneumonia. Traveler’s Diarrhea in Adults: For the treatment of Traveler’s Diarrhea due to susceptible strains of enterotoxigenic E. coli.

Vista Pharmaceuticals, Inc.


4 years ago OVAL WHITE VP 120 sulfamethoxazole and trimethoprim tablet

OVAL WHITE VP 120

4 years ago OVAL WHITE VP 120 sulfamethoxazole and trimethoprim tablet

VP 120 OVAL WHITE

HOW SUPPLIED:

SULFAMETHOXAZOLE AND TRIMETHOPRIM Double Strength tablets (white, scored, oblong), containing 800 mg sulfamethoxazole and 160 mg trimethoprim-bottles of 100 (NDC 61971-120-01) and 500 (NDC 61971-120-05). Imprint on tablets: VP 120.

SULFAMETHOXAZOLE AND TRIMETHOPRIM tablets (white, scored, round), containing 400 mg sulfamethoxazole and 80 mg trimethoprim-bottles of 100 (NDC 61971-115-01) and 500 (NDC 61971-115-05). Imprint on tablets: VISTA over 115. TABLETS SHOULD BE STORED AT 20° TO 25° C (68° to 77°F) ) [see USP Controlled Room Temperature] R . DISPENSE IN TIGHT, LIGHT RESIStanT CONTAINER R .


More pills like OVAL VP 120












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site